Cargando…

A Panel of Biomarkers Associates With Increased Risk for Cardiovascular Events in Women With Systemic Lupus Erythematosus

OBJECTIVE: The increase in cardiovascular events (CVEs) in systemic lupus erythematosus (SLE) is not fully explained by traditional risk factors. We previously identified four biomarkers (proinflammatory high‐density lipoprotein, leptin, soluble TNF‐like weak inducer of apoptosis (sTWEAK), and homoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skaggs, Brian J., Grossman, Jennifer, Sahakian, Lori, Perry, Lucas, FitzGerald, John, Charles‐Schoeman, Christina, Gorn, Alan, Taylor, Mihaela, Moriarty, John, Ragavendra, Nagesh, Weisman, Michael, Wallace, Daniel J., Hahn, Bevra H., McMahon, Maureen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063147/ https://www.ncbi.nlm.nih.gov/pubmed/33605563 http://dx.doi.org/10.1002/acr2.11223

Ejemplares similares

High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids
por: McMahon, Maureen, et al.
Publicado: (2011)

High score on PREDICTS is associated with 10-fold increased odds for the progression of subclinical atherosclerosis in SLE
por: McMahon, M, et al.
Publicado: (2012)

Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus
por: Zhu, Lisa, et al.
Publicado: (2022)

Comparison of PREDICTS atherosclerosis biomarker changes after initiation of new treatments in patients with SLE
por: McMahon, Maureen, et al.
Publicado: (2019)

Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis
por: Hahn, Bevra H, et al.
Publicado: (2008)

Cardiovascular Disease in Systemic Lupus Erythematosus
por: McMahon, Maureen, et al.
Publicado: (2021)

Thinking toward improved treatments of systemic lupus erythematosus
por: Hahn, BH, et al.
Publicado: (2012)

Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosus
por: Rullo, Ornella J, et al.
Publicado: (2013)

Identification and Contribution of Inflammation-Induced Novel MicroRNA in the Pathogenesis of Systemic Lupus Erythematosus
por: Singh, Ram P., et al.
Publicado: (2022)

Assessment of antibody levels to SARS-CoV-2 in patients with idiopathic inflammatory myopathies receiving treatment with intravenous immunoglobulin
por: Bae, Sangmee Sharon, et al.
Publicado: (2023)

Unmet needs: therapeutic standards of care
por: Hahn, Bevra
Publicado: (2013)

Serologic features of cohorts with variable genetic risk for systemic lupus erythematosus
por: Bhattacharya, Jyotsna, et al.
Publicado: (2018)

Seeing the wood for the trees: towards improved quantification of glial cells in central nervous system tissue
por: Healy, Sinéad, et al.
Publicado: (2018)

UPR Induction Prevents Iron Accumulation and Oligodendrocyte Loss in ex vivo Cultured Hippocampal Slices
por: Healy, Sinead, et al.
Publicado: (2018)

Patient Perspectives on Gout and Gout Treatments: A Patient Panel Discussion That Informed the 2020 American College of Rheumatology Treatment Guideline
por: Singh, Jasvinder A., et al.
Publicado: (2020)

Cardiovascular events and risk in patients with systemic lupus erythematosus: Systematic literature review and meta-analysis
por: Bello, Natalia, et al.
Publicado: (2022)

Prevalence of angina in patients with systemic lupus erythematosus
por: Ishimori, ML, et al.
Publicado: (2012)

Outcome measures in systemic lupus erythematosus: constructing a meaningful response index from existing clinical trial data
por: Forbess, Lindsy, et al.
Publicado: (2014)

Significant glial alterations in response to iron loading in a novel organotypic hippocampal slice culture model
por: Healy, Sinead, et al.
Publicado: (2016)

The role of the unfolded protein response in myelination
por: Naughton, Michelle C., et al.
Publicado: (2016)

Utility of the AVISE Connective Tissue Disease test in predicting lupus diagnosis and progression
por: Liang, Emily, et al.
Publicado: (2020)

Baseline Elevations of Leukotriene Metabolites and Altered Plasmalogens Are Prognostic Biomarkers of Plaque Progression in Systemic Lupus Erythematosus
por: Baig, Sahar, et al.
Publicado: (2022)

Interferon Genes Are Influenced by 17β-Estradiol in SLE
por: Singh, Ram P., et al.
Publicado: (2021)

Effects of Peptide-Induced Immune Tolerance on Murine Lupus
por: Singh, Ram P., et al.
Publicado: (2021)

Cellular and Molecular Phenotypes of pConsensus Peptide (pCons) Induced CD8(+) and CD4(+) Regulatory T Cells in Lupus
por: Singh, Ram P., et al.
Publicado: (2021)

CD8(+) T Regulatory Cells in Lupus
por: Singh, Ram P., et al.
Publicado: (2021)

In vivo analysis of fracture toughness of thyroid gland tumors
por: Ragavendra, Nagesh, et al.
Publicado: (2008)

The landscape of systemic lupus erythematosus in Brazil: An expert panel review and recommendations
por: Klumb, Evandro Mendes, et al.
Publicado: (2021)

A three-protein biomarker panel assessed in diagnostic tissue predicts death from prostate cancer for men with localized disease
por: Severi, Gianluca, et al.
Publicado: (2014)

Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosus
por: van Vollenhoven, Ronald F, et al.
Publicado: (2022)

Peptide-based immunotherapy in lupus: Where are we now?
por: P. Singh, Ram, et al.
Publicado: (2023)

Characterization of Intrinsic Radiation Sensitivity in a Diverse Panel of Normal, Cancerous and CRISPR-Modified Cell Lines
por: Liberal, Francisco D. C. Guerra, et al.
Publicado: (2023)

Calreticulin and other components of endoplasmic reticulum stress in rat and human inflammatory demyelination
por: Ní Fhlathartaigh, Mary, et al.
Publicado: (2013)

A multianalyte assay panel with cell-bound complement activation products demonstrates clinical utility in systemic lupus erythematosus
por: Alexander, Roberta Vezza, et al.
Publicado: (2021)

Evaluation of the Economic Benefit of Earlier Systemic Lupus Erythematosus (SLE) Diagnosis Using a Multivariate Assay Panel (MAP)
por: Clarke, Ann E., et al.
Publicado: (2020)

Suppression of Serum Interferon‐γ Levels as a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus Erythematosus
por: Cesaroni, Matteo, et al.
Publicado: (2021)

New-onset non-infectious pulmonary manifestations among patients with systemic lupus erythematosus in Sweden
por: Forbess, Lindsy J., et al.
Publicado: (2019)

Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at risk individuals
por: Jog, Neelakshi R., et al.
Publicado: (2019)

Observed impacts of the Covid-19 first wave on travel behaviour in Switzerland based on a large GPS panel
por: Molloy, Joseph, et al.
Publicado: (2021)

1400. Impact of a Multiplex Polymerase Chain Reaction Meningitis/Encephalitis Panel and Antimicrobial Stewardship Bundle on Antimicrobial Use in Patients with Suspected Meningitis or Encephalitis
por: Woodbury, Katelyn, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_clcb7tgole54bh6l6m443rl784